Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-controlled Case Series Study
Description
BACKGROUND: Guillain-Barré syndrome (GBS) has been inconsistently associated to some Covid-19 vaccines. We aimed to quantify the risk of GBS according to the type of Covid-19 vaccine in a large population.
